Faslodex Observations During Regular Use by Advanced Mammacarcinoma Patients

TerminatedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

December 31, 2009

Conditions
Breast Cancer
Trial Locations (43)

Unknown

Research Site, Alkmaar

Research Site, Almelo

Research Site, Almere Stad

Research Site, Amsterdam

Research Site, Apeldoorn

Research Site, Assen

Research Site, Bergen op Zoom

Research Site, Capelle aan den IJssel

Research Site, Delft

Research Site, Delfzijl

Research Site, Doetinchem

Research Site, Dokkum

Research Site, Dordrecht

Research Site, Drachten

Research Site, Ede Gld

Research Site, Eindhoven

Research Site, Geldrop

Research Site, Gorinchem

Research Site, Hardenberg

Research Site, Heerenveen

Research Site, Heerlen

Research Site, Hellevoetsluis

Research Site, Hilversum

Research Site, Hoogeveen

Research Site, Leiden

Research Site, Leiderdorp

Research Site, Leidschendam

Research Site, Meppel

Research Site, Nieuwegein

Research Site, Oss

Research Site, Roermond

Research Site, Rotterdam

Research Site, Stadskanaal

Research Site, Terneuzen

Research Site, The Hague

Research Site, Tilburg

Research Site, Utrecht

Research Site, Vlaardingen

Research Site, Winschoten

Research Site, Winterswijk

Research Site, Zeist

Research Site, Zevenaar

Research Site, Zwolle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY